News Archive

2019

December

Media Release / Dec 11, 2019

Novartis announces FDA filing acceptance of Xolair® (omalizumab) for treatment of nasal polyps

Read More
Media Release / Dec 09, 2019

Novartis Kymriah® demonstrates consistent efficacy and safety outcomes in US patients when used in real-world setting

Read More

November

Media Release / Nov 17, 2019

Novartis PARAGON-HF analyses suggest Entresto® benefit beyond HFrEF

Read More
Media Release / Nov 15, 2019

New Novartis medicine Adakveo® (crizanlizumab-tmca) approved by FDA to reduce frequency of pain crises in individuals living with sickle cell disease

Read More
Media Release / Nov 13, 2019

Novartis launches PsO at Work with music icon Cyndi Lauper to bring to life the impact psoriasis can have in the workplace

Read More
Media Release / Nov 11, 2019

New Novartis data to be presented at American Heart Association SS2019 suggest broader clinical benefit of Entresto in chronic heart failure

Read More
Media Release / Nov 08, 2019

Novartis receives FDA approval for BEOVU®, offering wet AMD patients vision gains and greater fluid reductions vs aflibercept

Read More

October

Media Release / Oct 08, 2019

Novartis STEP Program™ now accepting submissions for proposals that address unmet patient needs in cancer biomarker testing

Read More
Media Release / Oct 02, 2019

Novartis positive 52-week PREVENT data confirm Cosentyx® efficacy in addressing entire axSpA spectrum

Read More
Media Release / Oct 01, 2019

Novartis Entresto receives FDA approval for pediatric heart failure, helping to address critical unmet need for treatment options

Read More